Aurora Cannabis

Aurora Cannabis Inc. is a prominent player in the global cannabis industry, specializing in the cultivation, production, and sale of cannabis and cannabis-derived products. The company operates across Canada and internationally, offering a diverse range of products and services tailored to both medical and recreational users.

Products and Services

• Wide selection of cannabis strains, oils, capsules, and topical kits
• Ancillary products including vaporizers, grinders, and secure containers
• Patient support services through CanvasRX, focusing on cannabis counseling

Growth Outlook

• Recent quarterly revenue reached CAD 38.1 million, indicating potential recovery
• Strong gross profit margin of 47.7% in Q4 2026 suggests operational efficiency
• Current ratio of 5.94 indicates robust liquidity to support future growth

Financial Highlights

• Trailing twelve months (TTM) revenue of CAD 94.2 million reflects a solid market presence
• Net income for Q4 2026 was CAD -57 million, highlighting ongoing challenges
• Cash and cash equivalents totaled CAD 112.8 million, providing a buffer for operations

Aurora Cannabis Inc. has established itself as a significant entity in the cannabis sector, with a comprehensive portfolio of products and services. The company is actively engaged in research and development, aiming to innovate and expand its offerings. Despite facing financial challenges, recent quarterly results indicate a potential turnaround, with a notable increase in revenue and a strong gross profit margin. The company's liquidity position is robust, allowing it to navigate the evolving market landscape effectively. Investors may find Aurora's strategic initiatives and market presence noteworthy as the cannabis industry continues to mature.